Rocio Maseda
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics.
Journal: Frontiers in immunology
Published: January 16, 2026
Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring.
Journal: Nutrients
Published: November 28, 2025
Apremilast in chronic graft-versus-host disease: a paediatric case report.
Journal: Clinical and experimental dermatology
Published: September 10, 2024
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study.
Journal: Experimental dermatology
Published: March 05, 2024
Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa.
Journal: The British journal of dermatology
Published: May 04, 2023
Bloodstream Infection in Children With Epidermolysis Bullosa.
Journal: The Pediatric infectious disease journal
Published: February 16, 2023
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants.
Journal: JAMA dermatology
Published: March 02, 2022
Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.
Journal: Frontiers in medicine
Published: June 26, 2020
Intravenous Immunoglobulin Therapy for Gestational Pemphigoid Refractory to Conventional Treatment.
Journal: Actas dermo-sifiliograficas
Published: February 05, 2019
Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses.
Journal: The British journal of dermatology
Published: January 24, 2019
Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 20, 2018
Last Updated: 09/26/2026